Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

PIRS Pieris Pharmaceuticals

1.1500.0000.00%
Close 09/30 16:00 ET
1.1500.0000.00%
Post Mkt Price 09/30 16:00 ET
High
1.190
Open
1.160
Turnover
328.45K
Low
1.110
Pre Close
1.150
Volume
285.24K
Market Cap
85.57M
P/E(TTM)
Loss
52wk High
5.285
Shares
74.41M
P/E(Static)
Loss
52wk Low
1.100
Float Cap
61.81M
Bid/Ask %
89.47%
Historical High
9.750
Shs Float
53.75M
Volume Ratio
2.67
Historical Low
1.100
Dividend TTM
--
Div Yield TTM
--
P/B
1.93
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.53%
Amplitude
6.96%
Avg Price
1.151
Lot Size
1
Float Cap
61.81M
Bid/Ask %
89.47%
Historical High
9.750
Shs Float
53.75M
Volume Ratio
2.67
Historical Low
1.100
Dividend TTM
--
P/B
1.93
Dividend LFY
--
Turnover Ratio
0.53%
Amplitude
6.96%
Avg Price
1.151
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.
CEO: Mr. Stephen S. Yoder
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...